Natural killer lines and clones with apparent antigen specificity by unknown
Natural Killer Lines and Clones with Apparent
Antigen Specificity
By Noboru Suzuki,* Elisabetta Bianchi,* Hong Bass,"
Tomoko Suzuki,* Jeff Bender,* Ruggero Pardi,* Carol A. Brenner,t
James W. Larrick,# and Edgar G. Engleman*
From the 'Department ofPathology, Stanford University School ofMedicine, Stanford,
California 94305; and tGenelabs Incorporated, Reduvod City, California 94063
Summary
Fresh CD3 - ,CD16' lymphocytes that adhered to selected allogeneic lymphoblastoid cell lines
(LCL) were cultured with LCL in the presence of IIL2-containing medium. The resulting lines
as well as clones derived from these lines expressed CD16 and/or CD56, but lacked detectable
CD3 or TCR-ot/f3 or TCR-y/S complexes on the cell surface. Northern blot analysis failed to
detect CD3e or TCR-(3 transcripts, but revealed the presence of a TCR-y chain transcript in
one ofthese lines. In addition to displaying potent cytolytic activity against K562 erythroleukemia
cells (a classical NK target), the vast majority of these lines and clones lysed theirspecific stimulator
LCL to a significantly greater extent than irrelevant LCL. This selective killing was inhibited
by the addition of cold stimulator LCL or K562 cells, or anti-LFA 1 mAbs, but not by irrelevant
LCL or mAbs to CD3, class I or class II MHC antigens. These results indicate that some CD3 -
lymphocytes, phenotypically indistinguishable from NK cells, can recognize and lyse allogeneic
targets in a specific manner.
N
atural killer (NK) cells are defined as lymphocytes that
lyse certain transformed or virally infected targets
without prior sensitization or restriction for products of the
MHC (1, 2) . Although T cells (CD3+) have been described
with NK-like activity, classical NK cells are LGL that lack
CD3 and express CD16 and/or CD56 (3, 4). Despite the
fact that NK cells have a limited target cell range, no specific
NK-associated surface receptor or target ligand has yet been
defined, leading to speculation that such effector cells lack
a highly refined antigen recognition system. However, re-
cent studies from our laboratory suggest that some NK cells
lyse their targets with a high degree of specificity (5). In those
studies lymphocytes of NK phenotype (CD3 - ,CD16+) were
cultured for several weeks with allogeneic microvascular en-
dothelial cells (EC)t in the presence of 11,2-containing me-
dium. The resulting cell lines, which retained theirNK pheno-
type, lysed the original stimulating EC but not EC from
unrelated donors. Similarly, Ciccone et al. recently described
CD2+,CD3 - clones that lysed allogeneic lymphoid cells
with apparent specificity, although the expression of CD16
and CD56 on these clones was not reported (6).
In the current study we attempted to define conditions
for reproducibly generating allospecific effector lines from fresh
cells of NK phenotype, that is, from classical NK cells. The
'Abbreviations used in this paper: EC, endothelial cells; LCL, lympho-
blastoid cell line.
results suggest that at least some NK cells have the ability
to interact with allogeneic targets in a cognate manner.
Materials and Methods
Monoclonal Antibodies and Immunofuorescence Analysis.
￿
mAbs
used in this study were produced and purified in this laboratory
and immunofluorescence staining was performed as described (7).
Stained cells were analyzed in an Ortho CytofluorografSystem 50H
cell sorter (Ortho Diagnostic Systems, Inc., Raritan, NJ).
Generation ofNK Lines and Clones.
￿
PBL from healthy normal
volunteerswere isolated by Ficoll-Hypaque gradient centrifugation,
and monocytes and B cells were removed by passage over nylon-
wool columns. To obtain CD3- ,CD5- cells, cells devoid of mono-
cytes and B cells were incubated with anti-CD3 mAb and applied
to plastic petridishes precoated with goat anti-mouse Ig (panning)
as described (8). This procedure was repeated twice, and then the
nonadherent cells were incubated with anti-CD5 mAb and panned
on anti-mouse Ig to remove any residual CD5' cells. The resul-
tant lymphocyte population contained <0.5% CD3* cells and
>85% Leu 11c' (CD16) cells by flow cytometric analysis.
To generate NK lines and clones, purified CD3 - ,CD16' cells
were incubated at 37°C for 1 h on a monolayer ofirradiated(10,000
rad) LCL that had been bound to flat-bottomed microtiter wells
with CELL-TAK (BioPolymers, Inc., Farmington, CT). There-
after, cells not adherent to LCL were washed out and adherent cells
were cultured in medium supplemented with 11,2--containing su-
pernatant (conditioned medium) (9) at 37°C in 5% CO2/air.
After culture for 1 wk the growing cells were isolated on Ficoll-
Hypaque gradients, and maintained as bulk cultures in 48-well plates,
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was addedevery 2-3 d, and 101 irradiated original LCL were also
added weekly to each well. With this procedure multiple NK lines
and clones were obtained and maintained for more than 6 mo.
Northern Blot Analysis.
￿
Totalcellular RNAwas prepared from
freshNK lines usingtheguanidinium thiocyanate/cesium chloride
procedure. 15 ug of total RNAwas size fractionated in formalde-
hyde-1% agarose gels, transferred to nylon membranes, and hy-
bridized with TCR or CD3 probes using methods described ear-
lier (9). cDNA probes for TCR-/3 and --y have been described (9).
Two synthetic oligonucleotides were used to detect CD3e mes-
sages, whose sequences have been described (6).
Target Cells.
￿
The following cultured cell lines were used as
targets in cytotoxicity assays: K562, a proerythroblastic cell line
isolated from a patient with chronic myelogenous leukemia; and
LCLs, ARENT (HLAA2,2; B38,39; DR6,6), SKF (HLA-A24,30;
B18,w35; DR5,5),MSAB (HLAA1,2; B57,57;DR7,7), ND (HLA
A26,29; B7,55; DR9,10), LBF (HLAA30;;B13;; DR7, ), and
JEK (HLA-A2,11; B39,62; DR4, - ). None of the LCLs had de-
tectable surfaceIg on the basisofimmunofluorescentstaining (data
not shown).
Cytotoxicity Assays.
￿
NK cell lines and clones were tested for
cytotoxicity in 4-h 5'Cr-release assays as described (9). In experi-
ments designed to explore the role of cell surface molecules in cy-
totoxicity, mAbs were introduced andwere present during the4-h
"Cr-release assays.
Cold Target Inhibition Assays.
￿
Target cells were labeled with
"Cr as above and dispensed into 96-well plates at 2.5 x 10,
cells/well. Unlabeled (cold) target cells were added to the wells
at unlabeled/labeled target cell ratios ranging from 0:1 to 100:1.
Effector cellswere then addedat various effector/labeled target cell
ratios, and the plates were incubated at 37°C for a 4-h "Cr-release
assay.
N K-A
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Results
CD3- ,CD16+ cells were incubated for 1 h on LCL mono-
layers as described in Materials and Methods. Adherent cells
were cultured with irradiated LCL in the presence ofIIT2-con-
taining medium, and following 6 wk of continuous expan-
sion the resulting cell lines were analyzed in a flow cytom-
eter for the expression of several surface markers. As shown
in Fig. 1 for arepresentative line, allcells expressCD2, CD16,
andCD56, but lack expression of CD3, theTCRa/o (anti-
body WT31) or TCR-y/6 (antibody TCR-y/6-1). Multiple
clones were derived by limit dilution culture of these lines,
although the cloning efficiency was low(0.5-1.0%) and the
growth rate slow (doublingtime 48 h). Sixclones were gener-
ated in sufficient numbers to study in parallel with parental
cell lines. All were CD3- and CD56+, but only three of
six were CD16+ (data not shown). Transcription of TCR
genes andtheCD3e gene wasstudiedby means of Northern
blot analysis. As shown for two representative lines in Fig.
2, no message for TCR-/3 or CD3e was detectable. A TCR
y chain message was seen in one of three lines studied (two
lines shown in Fig. 2 C). Identicalresults were obtained with
amethod for detecting specific transcripts based on thePCR
(data not shown). In combination, the results of antibody
staining and mRNA analysis rule out thepossibility that con-
ventional CD3 or TCRmolecules areexpressedby these cells.
To determine whether these cells had cytolytic activity,
representative lines and clones were tested as effectors in 4-h
"Cr-release assays against the original stimulator LCL as
well as irrelevant LCLs and NK sensitive K562 cells. As shown
in Fig. 3, alllines andclones exhibitedpotent,dose-dependent
CD56 / 0 JCR
tk- tk-
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Figure 1.
￿
Two-color flow cytometric analysis of cell surface antigens on a cell line derived from fresh CD3-,CD16+ lymphocytes. After 6 wk
of continuous expansion in the presence of irradiated LCL feeders, a representative cell line was separated from feeder cells over a Ficoll-Hypaque
gradient and analyzed by two-color immunofluorescence in an Ortho System 50H cell sorter. The same staining pattern has been obtained
repeatedly over a 6-mo period of continued propagation of this line.Figure 2 .
￿
Northern blot analysis of TCR and CD3e gene products
in antigen-specific NK lines. (A) CM-, (B) TCR-0, (C) TCR--y .
(Lane 1) NK line 133 ; (lane 2) NK line 135 ; (lane 3) Jurkat leukemic
cells ; (lane 4) Peer leukemic cells ; (lane S) MSAB (B cell-LCL) .
lysis ofK562 cells . This is not surprising in light of the sur-
face phenotype (CD3 -,CD16+,CD56+,or CD3 - ,CD16- ,
CD56') of the effectors . On the other hand, we were sur-
prised to find that the lines and clones also lysed LCL targets
(Fig. 3) . Moreover, in the vast majority of experiments lysis
of the original stimulator LCL exceeded that of the other
LCLs . Similar results were obtained fromNK lines or clones
generated from multiple donors to three different stimulator
LCL (Fig. 3), suggesting that the apparent specificity of lysis
is not merely a consequence of differential sensitivity of the
target LCL to NK or LAK cell-mediated lysis. Both
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CD3 - ,CD16' and CD3 - ,CD16 - lines demonstrated selec-
tive cytolysis of their stimulatorLCL, making it unlikely that
the CD16 molecule (Fc^y receptor) played a role in the lysis
of these targets (data not shown) .
To further analyze the specificity of cytolysis, the LCL
stimulated NK lines and clones were used as effectors in cold
target inhibition assays . In these experiments, cold (unlabeled)
target cells (K562, specific stimulator LCL, or irrelevant LCLs)
were tested in varying numbers for the ability to inhibit cy-
tolysis of 5'Cr-labeled NK-sensitive K562 cells or specific
stimulator LCL . As shown in Fig . 4, A and C, specific killing
of the original stimulator line, ARENT, was inhibited by
the addition of unlabeled ARENT or K562 cells but not by
the addition of irrelevant unlabeled LCL . As shown in Fig.
4, B and D, unlabeled K562 cells inhibited the lysis of StCr-
labeled K562 cells, whereas unlabeled ARENT cells had little
if any inhibitory effect on the lysis of K562.
To explore the role of cell surface molecules involved in
theNK killing (K562 target) and specific LCL killing by these
lines and clones, cytotoxicity assays were carried out in the
presence ofselectedmAbs . Only anti-CD11a (LFA-Ioe), which
is known to inhibit a variety of interactions between leuko-
cyte effectors and their targets, completely inhibited killing
of both targets (data not shown). An anti-CD18 (LFA-1/3)
antibody partially inhibited lysis of both targets ; however,
inhibition was more potent when the specificLCL was tested .
In contrast, antibodies to CD3, HLA class I, or HLA-DR
at concentrations as high as 25 ,ug/ml had no detectable effect
on the lysis of either target .
Discussion
All of the CD3 - ,CD56+ and/or CD16+ lines and clones
described in this report lysed the allogeneic LCL with which
they had been cultured . Although absolute specificity for
original stimulatorLCL was not observed and all lines killed
the classical NK-sensitive target, K562, in most instances the
lines lysed their specific LCL stimulators to a greater extent
than irrelevantLCL . The selective killing was not due simply
to differences in sensitivity to cytolysis between various LCLs,
since LCLs susceptible to lysis by some effector lines were
not susceptible to lysis by others . Furthermore, the results
cannot be explained by the presence of contaminatingT cells
in the cultures, since no CD3, TCR-a/o, or TCR-y/b an-
tigens could be detected by immunofluorescence analysis with
a flow cytometer, and neither anti-CD3 nor anti-HLA mAbs,
which are potent inhibitors ofT cell-mediated lympholysis
(9), inhibited the killing by these lines and clones .
Some NK cells and IL-2-dependent NK lines have been
demonstrated to express truncated TCR-6 and -f3 transcripts
(10, 11) as well as CD3e transcript (12) . The CD2',CD3 -
allospecific lines described by Ciccone et al . had truncated
TCR-,l and CD3e messages (6) . In contrast, our antigen-
specific NK lines had no detectable CD3e or TCRf3 mes-
sages, although one line expressed TCR-y mRNA . While
the explanation for these differences is unknown, the com-U
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plete absence of TCR and CD3 transcripts from several of
our lines suggests that the products of these genes are not
required for either the allospecific or NK activity of the lines.
It is important to emphasize that the NK lines and clones
described in this study were derived from CD3 - ,CD16+
cells that adhered to the particular LCL chosen for use as
a stimulator. We have also generated NK lines and clones
from single CD3 - ,CD16+ cells cultured without an initial
adherence step in the presence of allogeneic LCL and high
(>50 U/ml) concentrations ofrIL2. However, while this ap-
proach yielded a large number ofrapidly growing NK clones,
the vast majority of these clones failed to demonstrate specific
lysisof theirfeeder LCL (data not shown). This suggests that
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Cytotoxic activity of CD3 - cell lines
and clones. Lines and clones generated as described in
the text were tested for cytotoxic activity against the
original stimulator LCL, irrelevant LCLS, and K562
cells, using a standard s1Cr-release assay as described
in Materials and Methods. Values represent the mean
percent killing of triplicate assays. The original stimu-
lators for each line and clone are indicated in paren-
theses.
an initial adherence step as well as an avoidance of high con-
centrations of IL -2 in the culture medium may be important
factors in the selective growth of the types of NK lines and
clones described in this report .
Cold target inhibition studies confirmed the specificity of
the NK lines and clones for their LCL stimulators. Thus,
unlabeled (cold) stimulator LCL blocked the killing of the
same targets which had been labeled with S'Cr, whereas
LCL that were not lysed by the effector lines failed to inhibit
the killing of specific targets. On the other hand, cold K562
cells not only inhibited the lysis of K562 but also inhibited
the lysis of specific stimulator LCL, whereas none of the LCL
blocked the killing of K562. One possible explanation forW
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Effect of unlabeled (cold) target cells on the cytolytic ac-
tivity of a CD3- line and a CD3- clone. Unlabeled target cells
(K562, specific stimulator LCL ARENT, or irrelevant LCLs) were
tested for their ability to inhibit the lysis of s'Cr-labeled specific
stimulator LCL ARENT (panel A for the line-D and panel C for the
clone-3) or K562 cells (panel B for the line and panel D for the
clone). An effector to SICr-labeled target ratio of 12:1 for B, C, and
D and 24:1 for A was maintained in all assays, as increasing numbers
of cold inhibitor cells were added.
this pattern is that the avidity of the NK clones for K562
cells is substantially higher than their avidity for LCL targets,
and binding of the clones to K562 cells prevents their access
to LCL.
These results raise the interesting possibility that despite
theirlack ofTCRot//3 or TCRy/S structures, some NK cells
interact with their targets in a cognate manner. Although
there is little evidence in the literature to support this con-
cept, it is noteworthy that previous attempts to absorb NK
activity with target cells have suggested heterogeneity ofboth
NK recognition and target structures (13, 14). Furthermore,
NK cells have been shown to mediate hybrid resistance to
parental bone marrow grafts (15, 16), a phenomenon that
appears genetically restricted and directed at the products of
the noncodominant hematopoietic histocompatibility (Hh)
genes (17). These observations are consistent with the cur-
rent results, as well as those of Ciccone et al. (6) and our
previous findings in which endothelial cells were used as stimu-
lators to generate target cell specific NK lines (5) . Although
the physiologic significance and molecular basis of these
findings are unknown, our results suggest that the traditional
view of NK cells as nonspecific effectors should be recon-
sidered.
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